GL1X · GenesisL1 explorer

Research workbench

HIV-1 protease complexed with an inhibitor lp-130

Analyse HIV-1 protease complexed with an inhibitor lp-130 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1ODY
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HIV-1 protease
EC
3.4.23.16
Ligands
LP1
Pockets
1 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BHIV-1 protease (EC 3.4.23.16)protein994% helix, 51% strand—

Ligands and binding sites

  • LP1 · 4-[2-(2-acetylamino-3-naphtalen-1-yl-propionylamino)-4-methyl-pentanoylamino]-3-hydroxy-6-methyl-heptanoic acid [1-(1-carbamoyl-2-naphthalen-1-yl-ethylcarbamoyl)-propyl]-amide · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13300.700.8338LP1

Interfaces

1 interface between chains.

  • A–B · 1866 Ų buried · 35 hydrogen bonds · protein-protein

Compared structures

  • 1ODY · HIV-1 protease complexed with an inhibitor lp-130 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.